SOUTH PLAINFIELD, N.J., Dec. 9, 2016 /PRNewswire/ — PuraCap Pharmaceutical LLC announced today the introduction of two new acne products in their Eptex™ line of intelligent, physiologic skin repair formulations, Eptex Controlled Release Acne Wash and Eptex Controlled Release Acne Relief Lotion. The Eptex non-prescription acne product line utilizes cutting-edge delivery systems and proven ingredients to effectively treat acne for patients with sensitive skin, and is available through healthcare professionals. PuraCap is the maker of EpiCeram® Controlled Release Skin Barrier Emulsion, a leading prescription product indicated for atopic dermatitis and related skin conditions. The introduction of Eptex acne products adds to PuraCap’s growing portfolio of dermatology products.
Both Eptex acne products utilize a controlled release Intelli-Target™ technology that delivers treatment where it’s needed and most effective, minimizing the side effects typically associated with acne treatments by delivering proven actives gradually over time. In addition, each product contains MultiSal Neolipids™ — foundational lipids for skin barrier repair, and are ideal for both teens and adults. Eptex is available exclusively through prescribing healthcare professionals.
“PuraCap has a strong, growing portfolio of dermatology products and continues to offer innovative solutions,” said Dahai Guo, CEO of PuraCap Pharmaceutical LLC. “We are committed to meeting the needs of people with dermatological conditions and are pleased to introduce Eptex Acne Wash and Acne Relief Lotion.”
“Now there is a new acne alternative which enables patients to reap the benefits of benchmark treatments while minimizing any potential side effects typically associated with these treatments,” says Elise Geiger, Vice President and General Manager of PuraCap’s Branded Rx division. “We look forward to partnering with physicians to provide these intelligent acne products to patients.” Physicians will offer Eptex acne products directly to their patients from the office, which will make it very easy for patients to begin treatment immediately.